{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:00:36Z","timestamp":1794646836094,"version":"4.9.1"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.atherosclerosis.2021.08.007","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T11:00:49Z","timestamp":1628161249000},"page":"24-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Autoimmune diseases in patients undergoing percutaneous coronary intervention: A risk factor for in-stent restenosis?"],"prefix":"10.1016","volume":"333","author":[{"given":"Martino","family":"Pepe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Napoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1725-0279","authenticated-orcid":false,"given":"Eugenio","family":"Carulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Moscarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Forleo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palma Luisa","family":"Nestola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Biondi-Zoccai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Favale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.atherosclerosis.2021.08.007_bib1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","volume":"5","author":"Libby","year":"2019","journal-title":"Atherosclerosis. Nat Rev Dis Primers"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2021.08.007_bib2","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1056\/NEJMra2000317","article-title":"Atherosclerotic plaque healing","volume":"383","author":"Vergallo","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2021.08.007_bib3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2018","journal-title":"Eur. Heart J."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2021.08.007_bib4","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.hlc.2018.07.012","article-title":"Autoimmune diseases may increase adverse cardiovascular events after percutaneous coronary intervention: a systematic review and meta-analysis","volume":"28","author":"Ma","year":"2019","journal-title":"Heart Lung Circ."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2021.08.007_bib5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/ncprheum0092","article-title":"Mechanisms of disease: atherosclerosis in autoimmune diseases","volume":"2","author":"Sherer","year":"2006","journal-title":"Nat. Clin. Pract. Rheumatol."},{"issue":"23","key":"10.1016\/j.atherosclerosis.2021.08.007_bib6","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.jacc.2010.07.028","article-title":"In-stent restenosis in the drug-eluting stent era","volume":"56","author":"Dangas","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2021.08.007_bib7","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0735-1097(97)00334-3","article-title":"Predictive factors of restenosis after coronary stent placement","volume":"30","author":"Kastrati","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2021.08.007_bib8","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.coph.2011.03.006","article-title":"Inhibition of human in-stent restenosis: a molecular view","volume":"11","author":"Giordano","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2021.08.007_bib9","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.amjcard.2013.05.076","article-title":"Correlation between degree of neointimal hyperplasia and incidence and characteristics of neoatherosclerosis as assessed by optical coherence tomography","volume":"112","author":"Vergallo","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2021.08.007_bib10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2147\/POR.S132439","article-title":"Coronary stents and vascular response to implantation: literature review","volume":"8","author":"Brancati","year":"2017","journal-title":"Pragmatic Observational Res."},{"key":"10.1016\/j.atherosclerosis.2021.08.007_bib11","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ijcard.2017.01.155","article-title":"Relationship between quantities of tissue prolapse after percutaneous coronary intervention and neointimal hyperplasia at follow-up on serial optical coherence tomography examination","volume":"241","author":"Sugiyama","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2021.08.007_bib12","first-page":"68","article-title":"Optical coherence tomography characteristics of in-stent restenosis are different between first and second generation drug eluting stents","volume":"3","author":"Kilickesmez","year":"2014","journal-title":"Int J Cardiol Heart Vessel"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2021.08.007_bib13","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3349\/ymj.2014.55.4.944","article-title":"Optical coherence tomographic observation of morphological features of neointimal tissue after drug-eluting stent implantation","volume":"55","author":"Lee","year":"2014","journal-title":"Yonsei Med. J."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2021.08.007_bib14","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ahj.2009.06.004","article-title":"Optical coherence tomography patterns of stent restenosis","volume":"158","author":"Gonzalo","year":"2009","journal-title":"Am. Heart J."},{"issue":"21","key":"10.1016\/j.atherosclerosis.2021.08.007_bib15","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1056\/NEJM199411243312107","article-title":"The pathogenesis of insulin-dependent diabetes mellitus","volume":"331","author":"Atkinson","year":"1994","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2021.08.007_bib16","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0735-1097(98)00286-1","article-title":"The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation","volume":"32","author":"Abizaid","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2021.08.007_bib17","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.amjcard.2005.07.043","article-title":"Impact of diabetes mellitus on angiographic and clinical outcomes in the drug-eluting stents era","volume":"96","author":"Yang","year":"2005","journal-title":"Am. J. Cardiol."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2021.08.007_bib18","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.amjcard.2019.08.015","article-title":"Impact of insulin-treated and noninsulin-treated diabetes mellitus in all-comer patients undergoing percutaneous coronary interventions with polymer-free biolimus-eluting stent (from the RUDI-FREE registry)","volume":"124","author":"Pepe","year":"2019","journal-title":"Am. J. Cardiol."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2021.08.007_bib19","doi-asserted-by":"crossref","first-page":"604","DOI":"10.5551\/jat.6965","article-title":"Origin of restenosis after drug-eluting stent implantation in hyperglycemia is inflammatory cells and thrombus","volume":"18","author":"Kwon","year":"2011","journal-title":"J. Atherosclerosis Thromb."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2021.08.007_bib20","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1161\/01.CIR.0000091257.27563.32","article-title":"Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I","volume":"108","author":"Creager","year":"2003","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2021.08.007_bib21","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1172\/JCI18127","article-title":"Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells","volume":"112","author":"Du","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"6865","key":"10.1016\/j.atherosclerosis.2021.08.007_bib22","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2021.08.007_bib23","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1210\/jc.2012-1364","article-title":"Peri-procedural tight glycemic control during early percutaneous coronary intervention is associated with a lower rate of in-stent restenosis in patients with acute ST-elevation myocardial infarction","volume":"97","author":"Marfella","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2021.08.007_bib24","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jdiacomp.2018.05.015","article-title":"Role of plasma glucose level on myocardial perfusion in ST-segment elevation myocardial infarction patients","volume":"32","author":"Pepe","year":"2018","journal-title":"J. Diabet. Complicat."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2021.08.007_bib25","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1161\/01.CIR.93.9.1613","article-title":"Potentiation of vasculopathy by insulin: implications from an NHLBI clinical alert","volume":"93","author":"Sobel","year":"1996","journal-title":"Circulation"},{"issue":"5 Suppl 1","key":"10.1016\/j.atherosclerosis.2021.08.007_bib26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0026-0495(92)90088-R","article-title":"The role of insulin resistance and hyperinsulinemia in coronary heart disease","volume":"41","author":"Reaven","year":"1992","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2021.08.007_bib27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/01.RES.36.2.319","article-title":"Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells","volume":"36","author":"Stout","year":"1975","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2021.08.007_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/ijem.IJEM_225_20","article-title":"RSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020","volume":"24","author":"Chawla","year":"2020","journal-title":"Indian J Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2021.08.007_bib29","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jvs.2005.11.061","article-title":"Role of adhesion molecules in the induction of restenosis after angioplasty in the lower limb","volume":"43","author":"Heider","year":"2006","journal-title":"J. Vasc. Surg."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2021.08.007_bib30","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/eurheartj\/ehn060","article-title":"Vascular endothelial growth factor protein levels and gene expression in peripheral monocytes after stenting: a randomized comparative study of sirolimus: eluting and bare metal stents","volume":"29","author":"Kochiadakis","year":"2008","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2021.08.007_bib31","doi-asserted-by":"crossref","first-page":"H772","DOI":"10.1152\/ajpheart.01234.2009","article-title":"Insulin enhances the effect of nitric oxide at inhibiting neointimal hyperplasia in a rat model of type 1 diabetes","volume":"299","author":"Varu","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2021.08.007_bib32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jss.2016.01.030","article-title":"Nitric oxide differentially affects proteasome activator 28 after arterial injury in type 1 and type 2 diabetic rats","volume":"202","author":"Tsihlis","year":"2016","journal-title":"J. Surg. Res."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2021.08.007_bib33","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/S0002-9149(98)00157-X","article-title":"Paradoxic decreases in atherosclerotic plaque mass in insulin-treated diabetic patients","volume":"81","author":"Kornowski","year":"1998","journal-title":"Am. J. Cardiol."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2021.08.007_bib34","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/hrt.2003.021014","article-title":"Anatomy of coronary disease in diabetic patients: an explanation for poorer outcomes after percutaneous coronary intervention and potential target for intervention","volume":"90","author":"Morgan","year":"2004","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2021.08.007_bib35","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1253\/circj.CJ-09-0274","article-title":"Rheumatoid arthritis: model of systemic inflammation driving atherosclerosis","volume":"73","author":"Ku","year":"2009","journal-title":"Circ. J."},{"key":"10.1016\/j.atherosclerosis.2021.08.007_bib36","doi-asserted-by":"crossref","first-page":"147354","DOI":"10.1155\/2012\/147354","article-title":"Atherosclerosis and rheumatoid arthritis: more than a simple association","volume":"2012","author":"Cavagna","year":"2012","journal-title":"Mediat. Inflamm."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2021.08.007_bib37","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/heartjnl-2015-308634","article-title":"Repeat revascularisation outcomes after percutaneous coronary intervention in patients with rheumatoid arthritis","volume":"102","author":"Sintek","year":"2016","journal-title":"Heart"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2021.08.007_bib38","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1096\/fj.201700327R","article-title":"IFN-\u03b3 aggravates neointimal hyperplasia by inducing endoplasmic reticulum stress and apoptosis in macrophages by promoting ubiquitin-dependent liver X receptor-\u03b1 degradation","volume":"31","author":"Zhao","year":"2017","journal-title":"Faseb. J."},{"key":"10.1016\/j.atherosclerosis.2021.08.007_bib39","doi-asserted-by":"crossref","first-page":"9846312","DOI":"10.1155\/2019\/9846312","article-title":"Therapeutic targeting of the proinflammatory IL-6-JAK\/STAT signalling pathways responsible for vascular restenosis in type 2 diabetes mellitus","volume":"2019","author":"Moshapa","year":"2019","journal-title":"Cardiol. Res. Pract."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2021.08.007_bib40","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/S0735-1097(00)01014-7","article-title":"Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting","volume":"36","author":"Kastrati","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2021.08.007_bib41","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1160\/TH02-09-0083","article-title":"Soluble E-selectin in cardiovascular disease and its risk factors. A review of the literature","volume":"90","author":"Rold\u00e1n","year":"2003","journal-title":"Thromb. Haemostasis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2021.08.007_bib42","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.atherosclerosis.2012.05.013","article-title":"Endothelial dysfunction in rheumatic autoimmune diseases","volume":"224","author":"Murdaca","year":"2012","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2021.08.007_bib43","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0008-6363(98)00302-2","article-title":"Cellular adhesion molecules on vascular smooth muscle cells","volume":"41","author":"Braun","year":"1999","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2021.08.007_bib44","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1161\/01.CIR.95.6.1515","article-title":"Inhibition of intimal hyperplasia after balloon injury by antibodies to intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1","volume":"95","author":"Yasukawa","year":"1997","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2021.08.007_bib45","first-page":"115","article-title":"Inflammation and endothelial dysfunction in rheumatoid arthritis","volume":"24","author":"Gonzalez-Gay","year":"2006","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.atherosclerosis.2021.08.007_bib46","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.biopha.2018.03.003","article-title":"Adiponectin as a potential therapeutic target for the treatment of restenosis","volume":"101","author":"Li","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2021.08.007_bib47","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.coph.2004.10.004","article-title":"Insulin resistance, hyperleptinemia and endothelial dysfunction in coronary restenosis","volume":"5","author":"Piatti","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"issue":"14","key":"10.1016\/j.atherosclerosis.2021.08.007_bib48","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.jacc.2012.11.068","article-title":"Oxidative stress and pathological changes after coronary artery interventions","volume":"61","author":"Juni","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2021.08.007_bib49","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijcard.2019.05.003","article-title":"Association between asymmetric dimethylarginine and in-stent restenosis tissue characteristics assessed by optical coherence tomography","volume":"289","author":"Huang","year":"2019","journal-title":"Int. J. Cardiol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2021.08.007_bib50","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/MCA.0b013e3283458a7d","article-title":"Paraoxonase and arylesterase activities in stent restenosis in bare metal stent","volume":"22","author":"Demirbag","year":"2011","journal-title":"Coron. Artery Dis."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2021.08.007_bib51","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3899\/jrheum.090782","article-title":"Role of circulating endothelial progenitor cells in patients with rheumatoid arthritis with coronary calcification","volume":"37","author":"Yiu","year":"2010","journal-title":"J. Rheumatol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2021.08.007_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101058","article-title":"The impact of endothelial progenitor cells on restenosis after percutaneous angioplasty of hemodialysis vascular access","volume":"9","author":"Wu","year":"2014","journal-title":"PloS One"},{"issue":"7347","key":"10.1016\/j.atherosclerosis.2021.08.007_bib53","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2021.08.007_bib54","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/BOR.0b013e32832effdd","article-title":"Antiphospholipid syndrome and systemic lupus erythematosus: are they separate entities or just clinical presentations on the same scale?","volume":"21","author":"Shoenfeld","year":"2009","journal-title":"Curr. Opin. Rheumatol."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2021.08.007_bib55","article-title":"Impact of antiphospholipid syndrome and\/or systemic lupus erythematosus on the long-term adverse cardiovascular outcomes in patients after percutaneous coronary intervention: a systematic review and meta-analysis","volume":"95","author":"Bundhun","year":"2016","journal-title":"Medicine (Baltim.)"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2021.08.007_bib56","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1536\/ihj.46.631","article-title":"Association between anticardiolipin antibodies and recurrent cardiac events in patients with acute coronary syndrome","volume":"46","author":"G\u00fcrlek","year":"2005","journal-title":"Int. Heart J."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2021.08.007_bib57","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1161\/01.CIR.102.11.1258","article-title":"Anticardiolipin antibodies and recurrent coronary events: a prospective study of 1150 patients. Thrombogenic Factors, and Recurrent Coronary Events Investigators","volume":"102","author":"Bili","year":"2000","journal-title":"Circulation"},{"issue":"8850","key":"10.1016\/j.atherosclerosis.2021.08.007_bib58","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0140-6736(93)91213-6","article-title":"Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus","volume":"341","author":"Vaarala","year":"1993","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2021.08.007_bib59","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/cvr\/cvx112","article-title":"A role for autoantibodies in atherogenesis","volume":"113","author":"Iseme","year":"2017","journal-title":"Cardiovasc. Res."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2021.08.007_bib60","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1536\/ihj.20-139","article-title":"Incidence and predictors of neoatherosclerosis in patients with early in-stent restenosis determined using optical coherence tomography","volume":"61","author":"Meng","year":"2020","journal-title":"Int. Heart J."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2021.08.007_bib61","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0002-9343(87)90762-5","article-title":"Dyslipoproteinemia in systemic lupus erythematosus. Effect of corticosteroids","volume":"83","author":"Ettinger","year":"1987","journal-title":"Am. J. Med."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2021.08.007_bib62","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/ard.2007.070367","article-title":"EULAR recommendations for the management of systemic lupus erythematosus. Report of a task force of the EULAR standing committee for international clinical studies including therapeutics","volume":"67","author":"Bertsias","year":"2008","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2021.08.007_bib63","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/00042737-199910000-00007","article-title":"Acute inflammatory intestinal vascular lesions and in situ abnormalities of the plasminogen activation system in Crohn's disease","volume":"11","author":"Desreumaux","year":"1999","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.atherosclerosis.2021.08.007_bib64","article-title":"Inflammatory bowel disease and acute coronary syndromes: from pathogenesis to the fine line between bleeding and ischemic risk","author":"Pepe","year":"2020","journal-title":"Inflamm. Bowel Dis."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2021.08.007_bib65","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2459\/JCM.0000000000000149","article-title":"Inflammatory bowel disease, liver diseases and endothelial function: is there a linkage?","volume":"16","author":"Ciccone","year":"2015","journal-title":"J. Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2021.08.007_bib66","first-page":"38","article-title":"Evaluation of relationship between common carotid artery intima-media thickness and coronary in-stent restenosis: a case-control study","volume":"10","author":"Bhavanadhar","year":"2018","journal-title":"Interv Med Appl Sci"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2021.08.007_bib67","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1177\/0003319713489876","article-title":"Is there an association between inflammatory bowel diseases and carotid intima-media thickness? Preliminary data","volume":"65","author":"Theocharidou","year":"2014","journal-title":"Angiology"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2021.08.007_bib68","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12872-016-0440-y","article-title":"High rate of in-stent restenosis after coronary intervention in carriers of the mutant mannose-binding lectin allele","volume":"17","author":"Bagyura","year":"2017","journal-title":"BMC Cardiovasc. Disord."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2021.08.007_bib69","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1084\/jem.20041431","article-title":"Mannan binding lectin as an adjunct to risk assessment for myocardial infarction in individuals with enhanced risk","volume":"201","author":"Saevarsdottir","year":"2005","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2021.08.007_bib70","first-page":"198","article-title":"Infection-susceptibility alleles of mannose-binding lectin are associated with increased carotid plaque area","volume":"48","author":"Hegele","year":"2000","journal-title":"J. Invest. Med."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2021.08.007_bib71","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1089\/thy.2012.0554","article-title":"Hashimoto's thyroiditis: celebrating the centennial through the lens of the Johns Hopkins hospital surgical pathology records","volume":"23","author":"Caturegli","year":"2013","journal-title":"Thyroid"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2021.08.007_bib72","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1210\/jc.2006-1075","article-title":"Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto's thyroiditis","volume":"91","author":"Taddei","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2021.08.007_bib73","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s12020-013-9952-8","article-title":"Autoimmune thyroid disease: a novel risk factor for atherosclerosis?","volume":"44","author":"McLeod","year":"2013","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2021.08.007_bib74","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/01.RES.88.3.313","article-title":"Thyroid hormone activation in human vascular smooth muscle cells: expression of type II iodothyronine deiodinase","volume":"88","author":"Mizuma","year":"2001","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2021.08.007_bib75","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4274\/jcrpe.2145","article-title":"Effects of thyroid autoimmunity on early atherosclerosis in euthyroid girls with hashimoto's thyroiditis","volume":"8","author":"\u0130\u015fg\u00fcven","year":"2016","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2021.08.007_bib76","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12020-012-9842-5","article-title":"Is autoimmune thyroiditis a risk factor for early atherosclerosis in premenopausal women even if in euthyroid status?","volume":"44","author":"Topaloglu","year":"2013","journal-title":"Endocrine"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2021.08.007_bib77","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/01.ATV.20.9.2094","article-title":"C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis","volume":"20","author":"Torzewski","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2021.08.007_bib78","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.numecd.2010.02.023","article-title":"Serum levels of adhesion molecules ICAM-1 and VCAM-1 and tissue inhibitor of metalloproteinases, TIMP-1, are elevated in patients with autoimmune thyroid disorders: relevance to vascular inflammation","volume":"21","author":"Jublanc","year":"2011","journal-title":"Nutr. Metabol. Cardiovasc. Dis."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2021.08.007_bib79","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/jcmm.13936","article-title":"The effects of stenting on coronary endothelium from a molecular biological view: time for improvement?","volume":"23","author":"Cornelissen","year":"2019","journal-title":"J. Cell Mol. Med."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2021.08.007_bib80","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00380-017-1062-8","article-title":"Correlation between endothelial dysfunction and myocardial damage in acute phase of Tako-Tsubo cardiomyopathy: brachial flow mediated dilation as a potential marker for assessment of patient with Tako-Tsubo","volume":"33","author":"Carbonara","year":"2018","journal-title":"Heart Ves."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2021.08.007_bib81","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1161\/01.CIR.0000151308.06673.D2","article-title":"Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation","volume":"111","author":"Patti","year":"2005","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2021.08.007_bib82","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.amjcard.2019.04.015","article-title":"Comparative effectiveness and safety of polymer-free biolimus-eluting stent and durable polymer everolimus-eluting stent in all-comer patients who underwent percutaneous coronary interventions","volume":"124","author":"Pepe","year":"2019","journal-title":"Am. J. Cardiol."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2021.08.007_bib83","doi-asserted-by":"crossref","first-page":"11324","DOI":"10.3390\/ijms150711324","article-title":"Endothelial dysfunction in chronic inflammatory diseases","volume":"15","author":"Steyers","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2021.08.007_bib84","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1373\/clinchem.2018.299636","article-title":"Low HDL cholesterol and high risk of autoimmune disease: two population-based cohort studies including 117341 individuals","volume":"65","author":"Madsen","year":"2019","journal-title":"Clin. Chem."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2021.08.007_bib85","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.epag.2015.03.001","article-title":"Dyslipidemia in type 1 diabetes mellitus: relation to diabetes duration, glycemic control, body habitus, dietary intake and other epidemiological risk factors","volume":"63","author":"Mona","year":"2015","journal-title":"Egyptian Pediatric Association Gazette"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2021.08.007_bib86","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13075-020-02307-8","article-title":"Effects of disease activity on lipoprotein levels in patients with early arthritis: can oxidized LDL cholesterol explain the lipid paradox theory?","volume":"22","author":"Fern\u00e1ndez-Ortiz","year":"2020","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2021.08.007_bib87","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s12026-016-8892-9","article-title":"Dyslipidemia in systemic lupus erythematosus","volume":"65","author":"Szab\u00f3","year":"2017","journal-title":"Immunol. Res."},{"issue":"38","key":"10.1016\/j.atherosclerosis.2021.08.007_bib88","doi-asserted-by":"crossref","first-page":"6331","DOI":"10.2174\/138161212803832245","article-title":"Atorvastatin sensitises vascular smooth muscle cells, but not endothelial cells, to TNF-\u03b1-induced cell death","volume":"18","author":"Giordano","year":"2012","journal-title":"Curr. Pharmaceut. Des."},{"issue":"23","key":"10.1016\/j.atherosclerosis.2021.08.007_bib89","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1016\/j.jacc.2014.01.054","article-title":"Innate and adaptive inflammation as a therapeutic target in vascular disease: the emerging role of statins","volume":"63","author":"Tousoulis","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"20","key":"10.1016\/j.atherosclerosis.2021.08.007_bib90","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1093\/eurheartj\/ehx002","article-title":"PCSK9 monoclonal antibodies reverse the pro-inflammatory profile of monocytes in familial hypercholesterolaemia","volume":"38","author":"Bernelot Moens","year":"2017","journal-title":"Eur. Heart J."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2021.08.007_bib91","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/clc.22042","article-title":"Relationship between endothelial functions and acetylsalicylic acid resistance in newly diagnosed hypertensive patients","volume":"35","author":"Sahin","year":"2012","journal-title":"Clin. Cardiol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2021.08.007_bib92","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1530\/EJE-07-0455","article-title":"Glucocorticoids and cardiovascular disease","volume":"157","author":"Walker","year":"2007","journal-title":"Eur. J. Endocrinol."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2021.08.007_bib93","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0002-9149(03)00148-6","article-title":"Meta-analysis of corticosteroid treatment in acute myocardial infarction","volume":"91","author":"Giugliano","year":"2003","journal-title":"Am. J. Cardiol."},{"issue":"19","key":"10.1016\/j.atherosclerosis.2021.08.007_bib94","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2021.08.007_bib95","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.semarthrit.2015.06.013","article-title":"Colchicine--Update on mechanisms of action and therapeutic uses","volume":"45","author":"Leung","year":"2015","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.atherosclerosis.2021.08.007_bib96","doi-asserted-by":"crossref","DOI":"10.4172\/2161-1459.1000181","article-title":"Methotrexate inhibits proliferation but not proteoglycan synthesis or glycosaminoglycan hyperelongation in human vascular smooth muscle cells","volume":"5","author":"Little","year":"2015","journal-title":"Clin. Exp. Pharmacol."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2021.08.007_bib97","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.3899\/jrheum.180171","article-title":"In-stent restenosis after drug-eluting stent implantation in rheumatoid arthritis: possible protective effect of methotrexate","volume":"45","author":"Kwon","year":"2018","journal-title":"J. Rheumatol."},{"issue":"20","key":"10.1016\/j.atherosclerosis.2021.08.007_bib98","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1161\/CIRCULATIONAHA.107.731877","article-title":"Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis","volume":"117","author":"Ikonomidis","year":"2008","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2021.08.007_bib99","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2143\/AC.59.2.2005169","article-title":"Anti-vascular cell adhesion molecule-1 and anti-very late antigen-4 monoclonal antibodies inhibit neointimal hyperplasia in the murine model of arterial injury","volume":"59","author":"Suzuki","year":"2004","journal-title":"Acta Cardiol."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2021.08.007_bib100","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with Canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915021012685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915021012685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:47:02Z","timestamp":1758156422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915021012685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":100,"alternative-id":["S0021915021012685"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.08.007","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune diseases in patients undergoing percutaneous coronary intervention: A risk factor for in-stent restenosis?","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}